Motohiro Kato

64PUBLICATIONS
263CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsInfant and child healthNeonatology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (64)

|Jun 25, 2026
Multifocal Neuroblastoma in Rubinstein-Taybi Syndrome Harboring a Novel CREBBP Variant Identified by Paired Whole Genome Sequencing.

|Apr 15, 2026
Decreased renal function predicts severe cytokine release syndrome after CAR-T-cell therapy for large B-cell lymphoma.

|Apr 09, 2026
Phenotypic Expansion and Molecular Implications in Recessive FUZ -Related Ciliopathy.

Yosuke Ogawa, Shota Kato, Kazuhiro Shiraga

|Apr 07, 2026
Trends in procedural closure of patent ductus arteriosus among children from 2011 to 2022 in Japan.

Kyosuke Ibi, Yoshihisa Miyamoto, Yuichiro Matsuo

|Feb 25, 2026
Combined Tyrosine Kinase Inhibitors and Chemotherapy Based on Minimal Residual Disease in Children With Ph<sup>+</sup> Acute Lymphoblastic Leukemia: A Phase 2 Single-Arm Trial, JCCG ALL-Ph13.

Atsushi Sato, Yuichi Kodama, Hirohide Kawasaki

|Feb 03, 2026
Identification of cellular hierarchy in paediatric acute myeloid leukaemia: The Japan Children's Cancer Group trial (JCCG AML-12).

Tomoya Komori, Tomoko Kawai, Yusuke Okuno

Pageof 11

Frequent Collaborators

18 joint publications

Masanori Yoshida

12 joint publications

Tomoo Osumi

8 joint publications

Kimikazu Matsumoto

8 joint publications

Shota Kato